{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:10:57Z","timestamp":1792782657238,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Udine","id":[{"id":"https:\/\/ror.org\/05ht0mh31","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To describe the long-term clinical course of Enhanced S-cone Syndrome (ESCS) in three siblings carrying the same NR2E3 variant, and to report therapeutic outcomes of choroidal neovascularization (CNV) and cystic macular changes during a 12-year follow-up from early childhood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective observational family case with literature review. Three siblings were examined periodically over 12 years beginning in early childhood. Clinical evaluation included best corrected visual acuity (BCVA), cycloplegic refraction, multimodal imaging. CNV was treated with intravitreal ranibizumab, while cystic macular changes were managed with topical carbonic anhydrase inhibitors (CAIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The three siblings shared a homozygous splice site variant (c.119\u20132\u00a0A\u2009&gt;\u2009C) in the NR2E3 gene and ERG showed ESCS pathognomonic features. In the eldest brother, acute onset esotropia secondary to visual impairment caused by CNV represented the first clinical manifestation. Following the onset of night blindness between ages 11 and 14, the older brother and sister developed macular cystic changes; however, topical CAIs were ineffective. Notably, they maintained stable visual acuity over a 12-year observation period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This family report underscores the clinical variability in ESCS and suggests that the visual acuity of young patients with ESCS remains stable, even in the presence of macular schisis. CNV was successfully treated with two intravitreal injections of ranibizumab, whilst topical CAIs proved ineffective for treating cystic patterns. Additional long-term studies are required to better understand the natural history of ESCS and improve therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00417-026-07300-6","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:29:40Z","timestamp":1781753380000},"page":"3017-3026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced S-cone syndrome in a family: first long-term (12-year) follow-up and literature review"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6236-6487","authenticated-orcid":false,"given":"Silvia","family":"Pignatto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asia Amelia","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Ursula","family":"Gavric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Megli\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9379-2704","authenticated-orcid":false,"given":"Enrico","family":"Redolfi De Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3746-141X","authenticated-orcid":false,"given":"Paolo","family":"Lanzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"7300_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/jamaophthalmol.2014.2343","volume":"132","author":"S Hull","year":"2014","unstructured":"Hull S, Arno G, Sergouniotis PI et al (2014) Clinical and molecular characterization of enhanced S-cone syndrome in children. JAMA Ophthalmol 132:1341\u20131349. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.2343","journal-title":"JAMA Ophthalmol"},{"key":"7300_CR2","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/humu.21096","volume":"30","author":"DF Schorderet","year":"2009","unstructured":"Schorderet DF, Escher P (2009) NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP). Hum Mutat 30:1475\u20131485. https:\/\/doi.org\/10.1002\/humu.21096","journal-title":"Hum Mutat"},{"key":"7300_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1073\/pnas.022533099","volume":"99","author":"AH Milam","year":"2002","unstructured":"Milam AH, Rose L, Cideciyan AV et al (2002) The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration. Proc Natl Acad Sci U S A 99:473\u2013478. https:\/\/doi.org\/10.1073\/pnas.022533099","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7300_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ng1386","volume":"36","author":"T L\u00e9veillard","year":"2004","unstructured":"L\u00e9veillard T, Mohand-Sa\u00efd S, Lorentz O et al (2004) Identification and characterization of rod-derived cone viability factor. Nat Genet 36:755\u2013759. https:\/\/doi.org\/10.1038\/ng1386","journal-title":"Nat Genet"},{"key":"7300_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/72777","volume":"24","author":"NB Haider","year":"2000","unstructured":"Haider NB, Jacobson SG, Cideciyan AV et al (2000) Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. Nat Genet 24:127\u2013131. https:\/\/doi.org\/10.1038\/72777","journal-title":"Nat Genet"},{"issue":"3","key":"7300_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","volume":"144","author":"AG Robson","year":"2022","unstructured":"Robson AG, Frishman LJ, Grigg J et al (2022) ISCEV Standard for full-field clinical electroretinography. Doc Ophthalmol 144(3):165\u2013177. https:\/\/doi.org\/10.1007\/s10633-022-09872-0","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"7300_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10633-019-09730-6","volume":"140","author":"I Perlman","year":"2020","unstructured":"Perlman I, Kondo M, Chelva E et al (2020) ISCEV extended protocol for the S-cone ERG. Doc Ophthalmol 140(2):95\u2013101. https:\/\/doi.org\/10.1007\/s10633-019-09730-6","journal-title":"Doc Ophthalmol"},{"issue":"5","key":"7300_CR8","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1167\/iovs.05-1629","volume":"49","author":"I Audo","year":"2008","unstructured":"Audo I, Michaelides M, Robson AG et al (2008) Phenotypic variation in enhanced S-cone syndrome. Invest Ophthalmol Vis Sci 49(5):2082\u20132093. https:\/\/doi.org\/10.1167\/iovs.05-1629","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"7300_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10633-012-9337-y","volume":"125","author":"I Cima","year":"2012","unstructured":"Cima I, Brecelj J, Sustar M et al (2012) Enhanced S-cone syndrome with preserved macular structure and severely depressed retinal function. Doc Ophthalmol 125(2):161\u2013168. https:\/\/doi.org\/10.1007\/s10633-012-9337-y","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"7300_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/IAE.0b013e31827e2306","volume":"33","author":"A Vincent","year":"2013","unstructured":"Vincent A, Robson AG, Holder GE (2013) Pathognomonic (diagnostic) ERGs. A review and update. Retina 33(1):5\u201312. https:\/\/doi.org\/10.1097\/IAE.0b013e31827e2306","journal-title":"Retina"},{"issue":"2","key":"7300_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.oret.2020.07.008","volume":"5","author":"ER de Carvalho","year":"2021","unstructured":"de Carvalho ER, Robson AG, Arno G et al (2021) Enhanced S-cone syndrome: spectrum of clinical, imaging, electrophysiologic, and genetic findings in a retrospective case series of 56 patients. Ophthalmol Retina 5(2):195\u2013214. https:\/\/doi.org\/10.1016\/j.oret.2020.07.008","journal-title":"Ophthalmol Retina"},{"key":"7300_CR12","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1177\/11206721241234396","volume":"34","author":"N Hassanpoor","year":"2024","unstructured":"Hassanpoor N, Ebrahimiadib N, Riazi-Esfahani H et al (2024) Bilateral helicoid peri-papillary sub-retinal fibrosis due to a biallelic NR2E3 mutation: Describing variable expressivity of a mutation. Eur J Ophthalmol 34:1761\u20131769. https:\/\/doi.org\/10.1177\/11206721241234396","journal-title":"Eur J Ophthalmol"},{"key":"7300_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.10.2008.1163","author":"AO Khan","year":"2009","unstructured":"Khan AO, Aldahmesh M, Meyer B (2009) The enhanced S-cone syndrome in children. BMJ case Rep. https:\/\/doi.org\/10.1136\/bcr.10.2008.1163. bcr10.2008.1163","journal-title":"BMJ case Rep"},{"key":"7300_CR14","doi-asserted-by":"publisher","unstructured":"Pichi F, Morara M, Veronese C et al (2013) Multimodal imaging in hereditary retinal diseases. J Ophthalmol 2013(634351). https:\/\/doi.org\/10.1155\/2013\/634351","DOI":"10.1155\/2013\/634351"},{"key":"7300_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/ICB.0000000000000594","volume":"13","author":"J Zerbib","year":"2019","unstructured":"Zerbib J, Blanco Garavito R, Gerber S et al (2019) RETINOCHOROIDAL ANASTOMOSIS ASSOCIATED WITH ENHANCED S-CONE SYNDROME. Retin Cases Brief Rep 13:295\u2013299. https:\/\/doi.org\/10.1097\/ICB.0000000000000594","journal-title":"Retin Cases Brief Rep"},{"issue":"4","key":"7300_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/s0002-9394(01)01428-3","volume":"133","author":"M Nakamura","year":"2002","unstructured":"Nakamura M, Hotta Y, Piao CH et al (2002) Enhanced S-cone syndrome with subfoveal neovascularization. Am J Ophthalmol 133(4):575\u2013577. https:\/\/doi.org\/10.1016\/s0002-9394(01)01428-3","journal-title":"Am J Ophthalmol"},{"key":"7300_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ceo.12578","volume":"44","author":"J Sambricio","year":"2016","unstructured":"Sambricio J, Tejada-Palacios P, Barcel\u00f3-Mendiguch\u00eda A (2016) Choroidal neovascularization, outer retinal tubulation and fundus autofluorescence findings in a patient with enhanced S-cone syndrome. Clin Exp Ophthalmol 44:69\u201371. https:\/\/doi.org\/10.1111\/ceo.12578","journal-title":"Clin Exp Ophthalmol"},{"key":"7300_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1242\/dmm.012112","volume":"6","author":"NK Wang","year":"2013","unstructured":"Wang NK, Lai CC, Liu CH et al (2013) Origin of fundus hyperautofluorescent spots and their role in retinal degeneration in a mouse model of Goldmann-Favre syndrome. Dis Model Mech 6:1113\u20131122. https:\/\/doi.org\/10.1242\/dmm.012112","journal-title":"Dis Model Mech"},{"key":"7300_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10633-010-9247-9","volume":"121","author":"MA Genead","year":"2010","unstructured":"Genead MA, Fishman GA, McAnany JJ (2010) Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome. Doc Ophthalmol 121:231\u2013240. https:\/\/doi.org\/10.1007\/s10633-010-9247-9","journal-title":"Doc Ophthalmol"},{"key":"7300_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ajo.2008.08.003","volume":"147","author":"A Iannaccone","year":"2009","unstructured":"Iannaccone A, Fung KH, Eyestone ME et al (2009) Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. Am J Ophthalmol 147:307\u2013312. https:\/\/doi.org\/10.1016\/j.ajo.2008.08.003","journal-title":"Am J Ophthalmol"},{"key":"7300_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/archopht.125.4.571","volume":"125","author":"M Ghajarnia","year":"2007","unstructured":"Ghajarnia M, Gorin MB (2007) Acetazolamide in the treatment of X-linked retinoschisis maculopathy. Arch Ophthalmol 125:571\u2013573. https:\/\/doi.org\/10.1001\/archopht.125.4.571","journal-title":"Arch Ophthalmol"},{"key":"7300_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/ICB.0b013e31818faa21","volume":"3","author":"M Hajali","year":"2009","unstructured":"Hajali M, Fishman GA (2009) Dorzolamide use in the management of macular cysts in a patient with enhanced s-cone syndrome. Retin Cases Brief Rep 3:121\u2013124. https:\/\/doi.org\/10.1097\/ICB.0b013e31818faa21","journal-title":"Retin Cases Brief Rep"},{"key":"7300_CR23","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1073\/pnas.0503021102","volume":"102","author":"EA Nagelhus","year":"2005","unstructured":"Nagelhus EA, Mathiisen TM, Bateman AC et al (2005) Carbonic anhydrase XIV is enriched in specific membrane domains of retinal pigment epithelium, Muller cells, and astrocytes. Proc Natl Acad Sci U S A 102:8030\u20138035. https:\/\/doi.org\/10.1073\/pnas.0503021102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7300_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10633-016-9527-0","volume":"132","author":"M Bu\u0161i\u0107","year":"2016","unstructured":"Bu\u0161i\u0107 M, Bjelo\u0161 M, Bosnar D et al (2016) Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child. Doc Ophthalmol 132:67\u201373. https:\/\/doi.org\/10.1007\/s10633-016-9527-0","journal-title":"Doc Ophthalmol"},{"key":"7300_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/BF00220229","volume":"63","author":"K Kawasaki","year":"1986","unstructured":"Kawasaki K, Mukoh S, Yonemura D et al (1986) Acetazolamide-induced changes of the membrane potentials of the retinal pigment epithelial cell. Doc Ophthalmol 63:375\u2013381. https:\/\/doi.org\/10.1007\/BF00220229","journal-title":"Doc Ophthalmol"},{"key":"7300_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0002-9394(14)76980-6","volume":"110","author":"MF Marmor","year":"1990","unstructured":"Marmor MF, Jacobson SG, Foerster MH et al (1990) Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity. Am J Ophthalmol 110:124\u2013134. https:\/\/doi.org\/10.1016\/s0002-9394(14)76980-6","journal-title":"Am J Ophthalmol"},{"key":"7300_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1159\/000495743","volume":"9","author":"F Bertoli","year":"2018","unstructured":"Bertoli F, Pignatto S, Rizzetto F et al (2018) A 5-Year-Old Case of Choroidal Neovascularization in Enhanced S-Cone Syndrome Treated with Ranibizumab. Case Rep Ophthalmol 9:510\u2013515. https:\/\/doi.org\/10.1159\/000495743","journal-title":"Case Rep Ophthalmol"},{"key":"7300_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s004170000186","volume":"238","author":"F Marano","year":"2000","unstructured":"Marano F, Deutman AF, Leys A et al (2000) Hereditary retinal dystrophies and choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 238:760\u2013764. https:\/\/doi.org\/10.1007\/s004170000186","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7300_CR29","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1097\/IAE.0000000000000407","volume":"35","author":"KD Badami","year":"2015","unstructured":"Badami KD, Sultana A et al (2015) Diagnostic and Therapeutic Challenges. Retina 35:1911\u20131918. https:\/\/doi.org\/10.1097\/IAE.0000000000000407","journal-title":"Retina"},{"key":"7300_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/EB.S9078","volume":"2","author":"MT Wong-Riley","year":"2010","unstructured":"Wong-Riley MT (2010) Energy metabolism of the visual system. Eye Brain 2:99\u2013116. https:\/\/doi.org\/10.2147\/EB.S9078","journal-title":"Eye Brain"},{"key":"7300_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10633-016-9555-9","volume":"133","author":"GK Broadhead","year":"2016","unstructured":"Broadhead GK, Grigg JR, McCluskey P et al (2016) Bevacizumab for choroidal neovascularization in enhanced S-cone syndrome. Doc Ophthalmol 133:139\u2013143. https:\/\/doi.org\/10.1007\/s10633-016-9555-9","journal-title":"Doc Ophthalmol"},{"key":"7300_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3129\/i10-123","volume":"46","author":"RP Kohly","year":"2011","unstructured":"Kohly RP, Muni RH, Kertes PJ et al (2011) Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: a retrospective consecutive case series. Can J Ophthalmol 46:46\u201350. https:\/\/doi.org\/10.3129\/i10-123","journal-title":"Can J Ophthalmol"},{"key":"7300_CR33","doi-asserted-by":"publisher","first-page":"e87942","DOI":"10.1371\/journal.pone.0087942","volume":"9","author":"NM Cruz","year":"2014","unstructured":"Cruz NM, Yuan Y, Leehy BD et al (2014) Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease. PLoS ONE 9:e87942. https:\/\/doi.org\/10.1371\/journal.pone.0087942","journal-title":"PLoS ONE"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07300-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07300-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07300-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:02:26Z","timestamp":1791208946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07300-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["7300"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07300-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}